erlotinib hydrochloride has been researched along with Smoking Cessation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caricato, M; Crucitti, P; Pezzuto, A; Russano, M; Scarlata, S; Stumbo, L; Tonini, G | 1 |
| Miller, AA; Petty, WJ; Waller, LL | 1 |
1 review(s) available for erlotinib hydrochloride and Smoking Cessation
| Article | Year |
|---|---|
Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liver; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Smoking; Smoking Cessation | 2010 |
1 trial(s) available for erlotinib hydrochloride and Smoking Cessation
| Article | Year |
|---|---|
"Impact of Smoking Cessation Treatment" on Lung Function and Response Rate in EGFR Mutated Patients: A Short-Term Cohort Study.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Forced Expiratory Volume; Genes, erbB-1; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Nicotinic Agonists; Respiratory Function Tests; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |